410 related articles for article (PubMed ID: 17040907)
1. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.
Zhang W; Swanson R; Xiong Y; Richard B; Olson ST
J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907
[TBL] [Abstract][Full Text] [Related]
2. The heparin-binding site of antithrombin is crucial for antiangiogenic activity.
Zhang W; Swanson R; Izaguirre G; Xiong Y; Lau LF; Olson ST
Blood; 2005 Sep; 106(5):1621-8. PubMed ID: 15905187
[TBL] [Abstract][Full Text] [Related]
3. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex.
McKeehan WL; Wu X; Kan M
J Biol Chem; 1999 Jul; 274(31):21511-4. PubMed ID: 10419453
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells.
Zhang W; Chuang YJ; Swanson R; Li J; Seo K; Leung L; Lau LF; Olson ST
Blood; 2004 Feb; 103(4):1185-91. PubMed ID: 14563633
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombin.
Richard B; Swanson R; Schedin-Weiss S; Ramirez B; Izaguirre G; Gettins PG; Olson ST
J Biol Chem; 2008 May; 283(21):14417-29. PubMed ID: 18375953
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence.
Schedin-Weiss S; Richard B; Hjelm R; Olson ST
Biochemistry; 2008 Dec; 47(51):13610-9. PubMed ID: 19035835
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells.
Larsson H; Sjöblom T; Dixelius J; Ostman A; Ylinenjärvi K; Björk I; Claesson-Welsh L
Cancer Res; 2000 Dec; 60(23):6723-9. PubMed ID: 11118058
[TBL] [Abstract][Full Text] [Related]
9. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
10. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
Krufka A; Guimond S; Rapraeger AC
Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
[TBL] [Abstract][Full Text] [Related]
11. Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase.
Kan M; Wu X; Wang F; McKeehan WL
J Biol Chem; 1999 May; 274(22):15947-52. PubMed ID: 10336501
[TBL] [Abstract][Full Text] [Related]
12. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms.
Roghani M; Moscatelli D
J Biol Chem; 1992 Nov; 267(31):22156-62. PubMed ID: 1429568
[TBL] [Abstract][Full Text] [Related]
13. Divalent cations and heparin/heparan sulfate cooperate to control assembly and activity of the fibroblast growth factor receptor complex.
Kan M; Wang F; To B; Gabriel JL; McKeehan WL
J Biol Chem; 1996 Oct; 271(42):26143-8. PubMed ID: 8824259
[TBL] [Abstract][Full Text] [Related]
14. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
Brown KJ; Hendry IA; Parish CR
J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic antithrombin induces global changes in the gene expression profile of endothelial cells.
Zhang W; Chuang YJ; Jin T; Swanson R; Xiong Y; Leung L; Olson ST
Cancer Res; 2006 May; 66(10):5047-55. PubMed ID: 16707426
[TBL] [Abstract][Full Text] [Related]
17. Oxidized antithrombin is a dual inhibitor of coagulation and angiogenesis: Importance of low heparin affinity.
Azhar A; Khan MS; Swaminathan A; Naseem A; Chatterjee S; Jairajpuri MA
Int J Biol Macromol; 2016 Jan; 82():541-50. PubMed ID: 26554332
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor.
Reich-Slotky R; Bonneh-Barkay D; Shaoul E; Bluma B; Svahn CM; Ron D
J Biol Chem; 1994 Dec; 269(51):32279-85. PubMed ID: 7528211
[TBL] [Abstract][Full Text] [Related]
19. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix.
Moscatelli D
J Biol Chem; 1992 Dec; 267(36):25803-9. PubMed ID: 1464594
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor receptors 1 and 2 interact differently with heparin/heparan sulfate. Implications for dynamic assembly of a ternary signaling complex.
Powell AK; Fernig DG; Turnbull JE
J Biol Chem; 2002 Aug; 277(32):28554-63. PubMed ID: 12034712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
